Nanosynex is an Israeli biotech startup created in 2017 that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes.
Today, Nanosynex is focused on the development and commercialization of an innovative Antimicrobial Susceptibility Test (AST). The technology is based on a purely phenotypic approach and uses a microfluidic disposable test cartridge platform and method that optimizes bacterial growth. This disruptive development was born from exciting research discoveries at the lab of Professor Shulamit Levenberg, Dean of the Technion Biomedical Engineering Faculty.
Nanosynex team is composed of passionate, dedicated business executives and top-notch engineers and supported by a network of experts, including strategic alliances with future distributors, that know how to bring this revolutionary scientific innovation to the market.
Advisory board & Kol
AWARDS & RECOGNITION
First place winners of “Suzhou Medtech Global Competition”, organized by TechCode (received a $4K cash prize and a fully subsidized trip to China to join the competition finals and meet potential partners)
Second place winners of “the Shenzhen Innovation and Entrepreneurship International Competition” (received a RMB 130K – ~$18K – cash prize and a fully subsidized trip to China to join the competition finals and meet potential partners)